Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings
about
A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysisPhenotypic microarrays suggest Escherichia coli ST131 is not a metabolically distinct lineage of extra-intestinal pathogenic E. coliIdentification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico.Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli.Escherichia coli ST131, an intriguing clonal groupPopulation structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England.Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.Frequent combination of antimicrobial multiresistance and extraintestinal pathogenicity in Escherichia coli isolates from urban rats (Rattus norvegicus) in Berlin, GermanyOccurrence of virulence genes associated with diarrheagenic Escherichia coli isolated from raw cow's milk from two commercial dairy farms in the Eastern Cape Province, South Africa.Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections.Comparative genome analysis identifies few traits unique to the Escherichia coli ST131 H30Rx clade and extensive mosaicism at the capsule locus."Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract"Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010)Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.Pathoadaptive Mutations of Escherichia coli K1 in Experimental Neonatal Systemic Infection.Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infectionsFluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutationsUropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract InfectionClinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.Coordination of Metabolism and Virulence Factors Expression of Extraintestinal Pathogenic Escherichia coli Purified from Blood Cultures of Patients with Sepsis.The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration.Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.Prevalence and spread of multidrug-resistant Escherichia coli including ST131 in different patient populations in the Euroregion Meuse-Rhine.The evolutionary path to extraintestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction in detectable recombination within the core genome.Increase in bacteraemia cases in the East Midlands region of the UK due to MDR Escherichia coli ST73: high levels of genomic and plasmid diversity in causative isolates.Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coliMultidrug-resistant Escherichia coli bacteremia.Clonal Diversity, Virulence Potential and Antimicrobial Resistance of Escherichia coli Causing Community Acquired Urinary Tract Infection in Switzerland.Characterization of four Escherichia coli clonal groups.
P2860
Q27011287-7000CB41-96A0-403D-8277-773B18F6B82EQ28073332-33B1DB2B-9457-43FF-9D29-6CA284C2F9A2Q28539662-5401D719-038B-4082-A81C-4932678AC258Q33634806-A31BC7AC-4943-4FD4-9201-78BA6A573313Q33952196-8AAC5882-179C-42DE-B9E9-0AE918DD1FE7Q34057648-73167DD5-F73F-496E-B05C-DE68D29AEBCBQ34057927-C11E797D-D285-4F45-A2DD-1AA0E3D0D3CBQ34315040-F3A22AA1-41EF-4E46-BB94-EB859E85C2ABQ34494097-7120ED64-AAA5-42F1-BE52-FC682D83BFF6Q34578486-AB8CCB3D-25D3-40EF-92A6-8A4539771080Q34916386-8E6FB978-E6E9-4674-8AD5-164B3C440D06Q35289728-3242A9C8-1B32-4E48-92B8-530C5B62FEE7Q35986381-5832BBD2-B8AF-406E-BEE7-3E3F5332CBCCQ36086484-9DC0C395-33DB-431C-B3B8-C80F04866887Q36172185-A5D0B540-F1B7-457A-924D-D7F312A0D21CQ36197313-1A9D033E-7DF5-45AD-9703-295FEE1B0EE2Q36505534-B6BFB6D1-E7FB-4E0B-A0B5-0EBFD7B20AC2Q36871802-B8E411FA-53E1-42BC-A700-E1779E16CE9EQ36891288-8C156E9B-0946-48D5-BC50-39A1F5B42658Q37001723-1A493540-ACFF-4F56-B579-9DDBB5D2C2A6Q37026380-FD1E5362-93B5-4090-A0FC-FD56027FD963Q37220795-8DF41F18-5D6A-4548-9CC7-F6CF7D3B49A5Q37236336-9C70E0C8-A746-4C73-B031-4F688DB12C4DQ37335855-990A8948-4ACA-4871-8DFB-36E8175EAE65Q37349628-7E8B1307-423A-4A0D-89CA-10364AB1F045Q37504205-015D0547-62BA-4FAC-98D1-F615851C2197Q37546192-17595D80-CC06-45C9-9D18-1E2699F79E85Q37612974-A7BE5C8F-2D38-4823-B5CD-CC90C4A048A4Q39375018-B28554C1-FA99-4E46-8F9E-90A7ABE0BAEBQ40299603-1CC6EB15-7123-4456-9E6C-6A37A77827FDQ40374496-D9782A9B-3E66-4D6D-A6F8-5975C8342090Q41220729-B6403BB0-2A2F-4F7F-A213-1C3864BB1BF4Q42931214-49068E20-DAEF-4E25-8038-F01267F03A6EQ47106522-1D2737A7-09B7-4320-B89E-BD95F628A5F7Q53729611-E412FC2E-DCE1-421D-810A-C60FE5FC2ED1
P2860
Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Molecular epidemiology of extr ...... ity and hospital care settings
@en
Molecular epidemiology of extr ...... ity and hospital care settings
@nl
type
label
Molecular epidemiology of extr ...... ity and hospital care settings
@en
Molecular epidemiology of extr ...... ity and hospital care settings
@nl
prefLabel
Molecular epidemiology of extr ...... ity and hospital care settings
@en
Molecular epidemiology of extr ...... ity and hospital care settings
@nl
P2093
P2860
P921
P356
P1476
Molecular epidemiology of extr ...... ity and hospital care settings
@en
P2093
Gemma Croxall
James Hale
Mark Achtman
Phil Cheetham
Vivienne Weston
P2860
P304
P356
10.1093/JAC/DKR349
P407
P577
2011-08-22T00:00:00Z